Managing Fabry disease with dietary adjustments, improving hypertension outcomes in CKD with aprocitentan, and advancing kidney treatment through innovative research on lucerastat.
Inflammatory pathways, innovative therapies, and the unique challenges faced by women highlight the urgent need for awareness, research, and tailored patient care strategies
Chiesi's launch of a grant for lysosomal storage disorder research, advancements in enzyme replacement therapy for Fabry patients, and the mental health challenges faced by individuals with Fabry disease.
